Skip to Content
COVID-19 Response and Update

Voices of Leadership Video Series

Our company is pivoting from a build phase to one of durable growth. Who are the leaders driving our key commercial areas?* What makes Amneal uniquely equipped to succeed in each? And what’s next? Some of our leaders share their candid thoughts below in these recent conversations…


*Important note - Amneal has three reportable business segments:
1) Generics (includes retail, injectables, biosimilars & international revenue), 2) Specialty and 3) AvKARE (includes distribution, government label and institutional revenue).